BEVERLY FRONING: Open Payments
NPI 1609584440 · CELINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 60 payments from 11 companies in 2025. Trend: 2023 $203 · 2024 $904 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $271 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $203 |
| Janssen Pharmaceuticals, Inc | 7 | $200 |
| Lundbeck LLC | 5 | $97 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Alkermes, Inc. | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, REXULTI, Auvelity, AUSTEDO XR, VIVITROL, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
